Evogliptin(DA-1229) is a potent and selective DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor) that can improve insulin resistance and delays the onset of diabetes. Evogliptin delays the onset of diabetes in young db/db mice and improves insulin sensitiv
Molecular Formula
C19H27ClF3N3O3
Molecular Weight
437.88
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.